Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
USRE36256E · kind E · reissue
115Cited by
10References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 1997 |
| Grant date | Jul 20, 1999 |
| Priority date | — |
| Expiry date | Dec 10, 2017 |
Classification
- Technology area (CPC —)General
Abstract
This invention relates to bis mono- and/or bicyclic aryl and/or heteroaryl compounds exhibiting protein tyrosine kinase inhibition activity. More specifically, it relates to the method of inhibiting abnormal cell proliferation in a patient suffering from a disorder characterized by such proliferation comprising the administration thereto of an EGF and/or PDGF receptor inhibiting effective amount of said bis mono- and/or bicyclic aryl and/or heteroaryl compound and to the preparation of said compounds and their use in pharmaceutical compositions used in this method.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.